Inventor
Russell D. Cink
Inventor
Grayslake, IL, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds17%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
C07JSteroids7%
A61KPreparations for medical, dental or toiletry purposes5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07KPeptides5%
C07HSugars2%
C12NMicroorganisms or enzymes2%
PatentTitleYear
10,689,675Enzymatic processes for the preparation of (+-)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (+-)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid202010,442,792Synthetic route to anti-viral agents201910,077,256Synthetic route to anti-viral agents20189,809,576'Synthetic route to anti-viral agents'20179,493,506'Macrocyclic hepatitis C serine protease inhibitors'20168,748,374'Macrocyclic hepatitis C serine protease inhibitors'20148,487,116'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20138,124,129'Crystalline form of the compound A-348441'20128,071,762'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20117,538,105'Anti-infective agents'20097,521,439'Glucocorticoid receptor ligands for the treatment of metabolic disorders'20097,378,414'Anti-infective agents'20087,375,126'Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'20087,259,186'Salts of fenofibric acid and pharmaceutical formulations thereof'20077,141,559'Glucocorticoid receptor ligands for the treatment of metabolic disorders'20066,797,721'Phorboxazole derivatives for treating cancer'20046,437,106'Process for preparing 6-o-substituted erythromycin derivatives'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2011Patents assigned to ABBOTT LAB (6)· patent assignee history
2002–2020Based in Grayslake, IL, US· patent location history
2006–2012Patents assigned to KAROBIO AB (3)· patent assignee history
2011–2014Patents assigned to CINK RUSSELL D (3)· patent assignee history
2011–2013Patents assigned to BAYBURT EROL K (2)· patent assignee history
2013–2020Patents assigned to ABBVIE INC (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE INC | 7 | 2013–2020 |
| ABBOTT LAB | 6 | 2002–2011 |
| CINK RUSSELL Dself | 3 | 2011–2014 |
| KAROBIO AB | 3 | 2006–2012 |
| BAYBURT EROL K | 2 | 2011–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Grayslake, Illinois, US | 17 | 2002–2020 |